Asymmetric left ventricular hypertrophy associated with morbid obesity mimicking familial hypertrophic cardiomyopathy

Singapore Medical Journal

Volumn 55, Issue 12, 2014, Pages e201-e204

  Wong, Raymond Ching Chiew ^a   Tan, Kong Bing ^b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Asymmetric left ventricular hypertrophy; Endomyocardial biopsy; Familial hypertrophic cardiomyopathy; Morbid obesity

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CASE REPORT; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; MORBID OBESITY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SLEEP DISORDERED BREATHING; COMPLICATION; DIFFERENTIAL DIAGNOSIS; HYPERTROPHY, LEFT VENTRICULAR;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; OBESITY, MORBID;

EID: 84916935076     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2014186     Document Type: Article

References (12)

1. Mehlman E, Bright JM, Jeckel K, et al. Echocardiographic evidence of left ventricular hypertrophy in obese dogs. J Vet Intern Med 2013; 27: 62-8.
2. Wong C, Marwick TH. Obesity cardiomyopathy: diagnosis and therapeutic implications. Nat Clin Pract Cardiovasc Med 2007; 4: 480-90.
3. Alpert MA, Fraley MA, Birchem JA, Senkottaiyan N. Management of obesity cardiomyopathy. Expert Rev Cardiovasc Ther 2005; 3: 225-30.
4. Saito T, Asai K, Sato S, et al. Myocardial alterations and clinical implications associated with recovery of cardiac function in dilated cardiomyopathy with obesity. Int J Cardiol 2013; 168: 144-50.
5. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-13.
6. Di Bello V, Santini F, Di Cori A, et al. Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study. J Am Soc Echocardiogr 2006; 19: 1063-71.
7. Kasper EK, Hruban RH, Baughman KL. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol 1992; 70: 921-4.
8. Khan MF, Movahed MR. Obesity cardiomyopathy and systolic function: Obesity is not independently associated with dilated cardiomyopathy. Heart Fail Rev 2013; 18: 207-17.
9. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010; 122: 352-60.
10. Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976; 60: 645-53.
11. Frankel DS, Vasan RS, D'Agostino RB Sr, et al. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 2009; 53: 754-62.
12. Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery. J Card Fail 2008; 14: 198-202.